Relapse of both small cell lung cancer and Lambert-Eaton myasthenic syndrome after a 13-year disease-free survival period
Lambert-Eaton myasthenic syndrome (LEMS) is a paraneoplastic syndrome and only 3% of small cell lung carcinoma (SCLC) patients have LEMS. Moreover, the recurrence of SCLC after a disease-free survival (DFS) of more than 10 years is rare. We report a patient who had a recurrence of both SCLC and LEMS after a 13-year DFS period. A 69-year-old man was diagnosed with LEMS and SCLC (cT0N2M0, stage IIIA) 13 years ago. Chemoradiotherapy was performed and a complete response was achieved. With anticancer treatment, the LEMS symptoms was alleviated. At the age of 82 years, gait disturbance appeared followed by left supraclavicular lymphadenopathy and further examination revealed the recurrence of SCLC. Careful screening for the recurrence of SCLC might be needed when the patient has recurrent or secondary paraneoplastic neurological syndrome even after a long DFS period.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
Chinese journal of cancer - 35(2016), 1 vom: 02. Juli, Seite 63 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Asano, Fumio [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 14.03.2017 Date Revised 13.11.2018 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s40880-016-0127-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM261988573 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM261988573 | ||
003 | DE-627 | ||
005 | 20231224200756.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s40880-016-0127-x |2 doi | |
028 | 5 | 2 | |a pubmed24n0873.xml |
035 | |a (DE-627)NLM261988573 | ||
035 | |a (NLM)27370896 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Asano, Fumio |e verfasserin |4 aut | |
245 | 1 | 0 | |a Relapse of both small cell lung cancer and Lambert-Eaton myasthenic syndrome after a 13-year disease-free survival period |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.03.2017 | ||
500 | |a Date Revised 13.11.2018 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Lambert-Eaton myasthenic syndrome (LEMS) is a paraneoplastic syndrome and only 3% of small cell lung carcinoma (SCLC) patients have LEMS. Moreover, the recurrence of SCLC after a disease-free survival (DFS) of more than 10 years is rare. We report a patient who had a recurrence of both SCLC and LEMS after a 13-year DFS period. A 69-year-old man was diagnosed with LEMS and SCLC (cT0N2M0, stage IIIA) 13 years ago. Chemoradiotherapy was performed and a complete response was achieved. With anticancer treatment, the LEMS symptoms was alleviated. At the age of 82 years, gait disturbance appeared followed by left supraclavicular lymphadenopathy and further examination revealed the recurrence of SCLC. Careful screening for the recurrence of SCLC might be needed when the patient has recurrent or secondary paraneoplastic neurological syndrome even after a long DFS period | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Lambert–Eaton myasthenic syndrome | |
650 | 4 | |a P/Q-type anti-voltage-gated calcium channel antibody | |
650 | 4 | |a Paraneoplastic neurological syndrome | |
650 | 4 | |a Paraneoplastic syndrome | |
650 | 4 | |a Small cell lung carcinoma | |
700 | 1 | |a Watanabe, Keisuke |e verfasserin |4 aut | |
700 | 1 | |a Shinkai, Masaharu |e verfasserin |4 aut | |
700 | 1 | |a Tei, Yoshitaka |e verfasserin |4 aut | |
700 | 1 | |a Mishina, Kei |e verfasserin |4 aut | |
700 | 1 | |a Tanabe, Mikiko |e verfasserin |4 aut | |
700 | 1 | |a Ishii, Hiroshi |e verfasserin |4 aut | |
700 | 1 | |a Shinoda, Masahiro |e verfasserin |4 aut | |
700 | 1 | |a Shimokawaji, Tadasuke |e verfasserin |4 aut | |
700 | 1 | |a Kudo, Makoto |e verfasserin |4 aut | |
700 | 1 | |a Kaneko, Takeshi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Chinese journal of cancer |d 2010 |g 35(2016), 1 vom: 02. Juli, Seite 63 |w (DE-627)NLM194018172 |x 1000-467X |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2016 |g number:1 |g day:02 |g month:07 |g pages:63 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s40880-016-0127-x |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 35 |j 2016 |e 1 |b 02 |c 07 |h 63 |